Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-077-7 | CAS number: 629-15-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral: LD50 (guinea pig, m/f) = 390 mg/kg bw (lowest dose descriptor available)
Inhalation: LC50 (rat, m/f) > 5.05 mg/L
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 390 mg/kg bw
- Quality of whole database:
- The available information comprises adequate, reliable (Klimisch score 2) and consistent studies, and is thus sufficient to fulfil the standard information requirements set out in Annex VII, 8.5, of Regulation (EC) No 1907/2006.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- The available information comprises an adequate and reliable study (Klimisch score 1), and is thus sufficient to fulfil the standard information requirements set out in Annex VIII, 8.5, of Regulation (EC) No 1907/2006.
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Oral
The acute oral toxicity of Ethylene diformate (and further glycol derivatives) was investigated in two early studies conducted in rats and guinea pigs (Smyth, 1941). Groups of ca. 10 animals (male rats and male and female guinea pigs) were given the test substance as a 5% dispersion in 1% aqueous "Tergitol" penetrant 7 (sodium sulfate of heptadecyl alcohols) by single oral gavage. The dose levels administered were not explicitly reported, but it can be assumed that the maximum dose level was in the order of 5000 mg/kg bw. The observation period following administration was up to 14 days.
Mortality data were summarised for all substances tested. Therefore, no substance specific data were reported. According to the authors, most deaths occurred within the first 48 h post-dose, but all deaths within 14 days post-administration were taken into account for calculation of LD50 values.
The test substance was tested along with other glycol esters. For this substance group, (near) fatal doses caused no narcosis but various degrees of sluggish depressed function.
Gross pathology findings were summarised for all substances tested. According to the authors, all doses caused some degree of irritation of the digestive tract. The primary target organ was the kidney; blood in urine and free blood beneath the capsule were seen at the highest dosages. The liver was less affected, but orange or reddish bile was often observed. Glycol esters were reported to produce livers of bright eosin colour.
The calculated oral LD50 values for male rats and male/female guinea pigs were 1510 and 390 mg/kg bw, respectively. The substance is therefore considered to be harmful if swallowed.
Inhalation
The acute inhalation toxicity of Ethylene diformate was evaluated in a study performed according to OECD guideline 403 under GLP conditions (Griffiths, 2012). A group of 10 male and female RccHan:WIST rats were nose-only exposed to 5.05 mg/L (analytical concentration) for 4 h. The animals were observed for a period of 14 days following administration.
No mortality occurred. During exposure increased respiratory rate and hunched posture were observed; however, all animals recovered during Days 3 to 4 after exposure. Hunched posture, pilo-erection, red-brown staining around the eyes and snout were seen in animals for short periods on removal from the chamber following the exposure period. Wet fur is commonly recorded both during and for a short period after exposure. These observations were thus considered to be associated with the restraint procedure and not indicative of toxicity. Necropsy and body weight development revealed no substance-related adverse findings.
Therefore, the LC50 for male and female rats was greater than 5.05 mg/L, and the substance is considered to be not toxic after acute exposure by inhalation.
Dermal
This information is not available.
The substance fulfils the criteria for classification as skin corrosive (Category 1B) according to Regulation (EC) No 1272/2008. Therefore, an acute dermal toxicity study does not need to be conducted in accordance with Column 2 of Annex VIII, Section 8.5, of Regulation (EC) No 1907/2006.
Conclusions for acute toxicity
The available data on the acute toxicity of Ethylene diformate comprise studies by the oral and inhalation routes. The substance has been tested for acute oral toxicity in rats (males) and guinea pigs (males and females) resulting in oral LD50 values of 1510 and 390 mg/kg bw, respectively. In an acute toxicity study in male and female rats exposed by inhalation, the LC50 was estimated to be greater than 5.05 mg/L (analytical concentration).
The substance is therefore considered to be harmful if swallowed but not toxic by inhalation.
Information on the acute dermal toxicity of Ethylene diformate is not available. The substance is, however, classified for skin corrosion (Category 1B) and therefore, an acute dermal toxicity study does not need to be conducted.
Justification for selection of acute toxicity – oral endpoint
The selected study is the most adequate and reliable study with the lowest dose descriptor.
Justification for selection of acute toxicity – inhalation endpoint
There is only one study available.
Justification for classification or non-classification
The available data on the acute oral toxicity of Ethylene diformate meet the classification criteria for Acute toxicity Category 4 (H302: Harmful if swallowed) according to Regulation (EC) 1272/2008 and for R22 (Harmful if swallowed) according to Directive 67/548/EEC.
The available data on the acute toxicity by inhalation of Ethylene diformate do not meet the classification criteria according to Regulation (EC) 1272/2008 or according to Directive 67/548/EEC, and are therefore conclusive but not sufficient for classification.
There are no data available on acute dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.